Kelleher Financial Advisors Purchases Shares of 1,198 Danaher Corporation $DHR

Kelleher Financial Advisors acquired a new position in Danaher Corporation (NYSE:DHR) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm acquired 1,198 shares of the conglomerate’s stock, valued at approximately $237,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Pacific Capital Partners Ltd purchased a new position in shares of Danaher during the 1st quarter worth about $7,175,000. CWM LLC grew its position in Danaher by 36.9% during the first quarter. CWM LLC now owns 30,811 shares of the conglomerate’s stock valued at $6,316,000 after buying an additional 8,313 shares during the period. MQS Management LLC purchased a new stake in shares of Danaher during the first quarter worth $225,000. Sigma Planning Corp raised its holdings in Danaher by 10.1% in the 1st quarter. Sigma Planning Corp now owns 11,279 shares of the conglomerate’s stock valued at $2,312,000 after buying an additional 1,036 shares during the period. Finally, OVERSEA CHINESE BANKING Corp Ltd raised its position in Danaher by 3,673.5% in the 1st quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 38,037 shares of the conglomerate’s stock valued at $7,812,000 after purchasing an additional 37,029 shares in the last quarter. Institutional investors own 79.05% of the company’s stock.

Danaher Trading Up 2.2%

Shares of NYSE:DHR opened at $215.80 on Wednesday. The company has a market capitalization of $152.43 billion, a P/E ratio of 44.49, a P/E/G ratio of 3.28 and a beta of 0.81. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.52 and a quick ratio of 1.10. The business’s 50 day simple moving average is $204.36 and its 200 day simple moving average is $200.64. Danaher Corporation has a 1 year low of $171.00 and a 1 year high of $258.23.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Tuesday, October 21st. The conglomerate reported $1.89 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.72 by $0.17. Danaher had a net margin of 14.44% and a return on equity of 10.92%. The firm had revenue of $6.05 billion during the quarter, compared to analysts’ expectations of $6 billion. During the same period last year, the company earned $1.71 earnings per share. The business’s revenue was up 4.4% on a year-over-year basis. Danaher has set its FY 2025 guidance at 7.700-7.800 EPS. On average, research analysts anticipate that Danaher Corporation will post 7.63 EPS for the current fiscal year.

Danaher Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, October 31st. Investors of record on Friday, September 26th were paid a $0.32 dividend. The ex-dividend date was Friday, September 26th. This represents a $1.28 annualized dividend and a dividend yield of 0.6%. Danaher’s dividend payout ratio is presently 26.39%.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Guggenheim restated a “buy” rating and issued a $250.00 price objective on shares of Danaher in a research note on Wednesday, July 23rd. Wall Street Zen downgraded shares of Danaher from a “buy” rating to a “hold” rating in a research report on Monday. JPMorgan Chase & Co. increased their price objective on shares of Danaher from $260.00 to $270.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 22nd. Robert W. Baird set a $247.00 price target on Danaher in a research note on Wednesday, October 22nd. Finally, Evercore ISI raised their target price on Danaher from $226.00 to $245.00 and gave the company an “outperform” rating in a research note on Tuesday, October 7th. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $243.39.

Insider Transactions at Danaher

In related news, Director Teri List sold 2,778 shares of the stock in a transaction that occurred on Friday, August 22nd. The shares were sold at an average price of $211.06, for a total transaction of $586,324.68. Following the transaction, the director owned 20,751 shares in the company, valued at $4,379,706.06. This represents a 11.81% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is currently owned by insiders.

Danaher Profile

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.